Joshua B. Muntner

SVP Business Development, CONTRAFECT Corp.

Companies

Cardiff Oncology, Inc.Chief financial officer Apr 16, 2026 to now¹
CONTRAFECT CorpSVP Business Development Nov 4, 2015 to Feb 7, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cardiff Oncology, Inc. CRDF500 shares³$450 at $0.90Apr 16, 2026

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCardiff Oncology, Inc., Chief financial officer
2
SEC EDGARCONTRAFECT Corp, SVP Business Development
3
SEC EDGARCardiff Oncology, Inc. shares after the filing of Apr 16, 2026